Dynamic morphological changes in Libman-Sacks endocarditis under different anticoagulation regimens.
作者信息
Kitano Takaya, Sengoku Kaoruko, Itotagawa Eri, Todo Kenichi
机构信息
Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
出版信息
BMJ Case Rep. 2019 Apr 4;12(4):e229909. doi: 10.1136/bcr-2019-229909.
Abstract
摘要
相似文献
1
Dynamic morphological changes in Libman-Sacks endocarditis under different anticoagulation regimens.不同抗凝方案下Libman-Sacks心内膜炎的动态形态学变化。
BMJ Case Rep. 2019 Apr 4;12(4):e229909. doi: 10.1136/bcr-2019-229909.
2
Aortic valve replacement for Libman-Sacks endocarditis.利布曼-萨克斯心内膜炎的主动脉瓣置换术。
Ann Thorac Surg. 2009 Aug;88(2):669-71. doi: 10.1016/j.athoracsur.2008.11.074.
3
Libman-Sacks endocarditis and stroke.
Rev Port Cardiol. 2002 May;21(5):629-31.
4
Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study.经胸超声心动图与经食管超声心动图检测Libman-Sacks心内膜炎的随机对照研究
J Rheumatol. 2008 Feb;35(2):224-9. Epub 2007 Dec 15.
5
Libman-Sacks endocarditis and cerebral embolization in antiphospholipid syndrome.抗磷脂综合征中的Libman-Sacks心内膜炎和脑栓塞
Eur J Echocardiogr. 2008 Jan;9(1):192-3. doi: 10.1093/ejechocard/jem067.
6
Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution.系统性红斑狼疮中的Libman-Sacks心内膜炎：患病率、关联因素及演变
Am J Med. 2007 Jul;120(7):636-42. doi: 10.1016/j.amjmed.2007.01.024.
7
8
Libman-Sacks Endocarditis: Detection, Characterization, and Clinical Correlates by Three-Dimensional Transesophageal Echocardiography.利布曼-萨克斯心内膜炎：经三维经食管超声心动图检测、特征分析及临床相关性研究
J Am Soc Echocardiogr. 2015 Jul;28(7):770-9. doi: 10.1016/j.echo.2015.02.011. Epub 2015 Mar 22.
9
Unusual location of the Libman-Sacks endocarditis in a teenager: a case report.青少年Libman-Sacks心内膜炎的罕见部位：一例报告
Cardiol Young. 2016 Feb;26(2):365-7. doi: 10.1017/S1047951115000712. Epub 2015 May 14.
10
Antiphospholipid syndrome masquerading as a case of infective endocarditis.伪装成感染性心内膜炎病例的抗磷脂综合征。
BMJ Case Rep. 2018 Jun 4;2018:bcr-2018-224404. doi: 10.1136/bcr-2018-224404.
引用本文的文献
1
Heterogeneity of Stroke in Patients with Systemic Lupus Erythematosus.系统性红斑狼疮患者的卒中异质性。
Intern Med. 2022;61(20):3045-3052. doi: 10.2169/internalmedicine.9228-21. Epub 2022 Oct 15.
2
Culture-negative endocarditis with neurologic presentations and dramatic response to heparin: a case report.神经表现且对肝素反应明显的Culture-negative 心内膜炎：病例报告。
BMC Infect Dis. 2020 Jul 6;20(1):476. doi: 10.1186/s12879-020-05206-0.
本文引用的文献
1
Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.直接口服抗凝剂治疗的抗磷脂综合征患者血栓形成风险增加。来自国际患者水平数据荟萃分析的结果。
Autoimmun Rev. 2018 Oct;17(10):1011-1021. doi: 10.1016/j.autrev.2018.04.009. Epub 2018 Aug 11.
2
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.利伐沙班与华法林在抗磷脂抗体综合征高危患者中的比较。
Blood. 2018 Sep 27;132(13):1365-1371. doi: 10.1182/blood-2018-04-848333. Epub 2018 Jul 12.
3
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.利伐沙班与华法林治疗血栓形成性抗磷脂综合征患者（无论是否合并系统性红斑狼疮）（RAPS）：一项随机、对照、开放标签的2/3期非劣效性试验。
Lancet Haematol. 2016 Sep;3(9):e426-36. doi: 10.1016/S2352-3026(16)30079-5.
4
Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome.原发性抗磷脂综合征心肌梗死后抗凝治疗使赘生物消退
J Am Soc Echocardiogr. 1997 Oct;10(8):877-80. doi: 10.1016/s0894-7317(97)70050-6.
5
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.抗磷脂综合征中的心脏瓣膜受累（Libman-Sacks 心内膜炎）。
Circulation. 1996 Apr 15;93(8):1579-87. doi: 10.1161/01.cir.93.8.1579.
Zotero 插件